Xeljanz Approved For Rheumatoid Arthritis Treatment By FDA

The U.S. Food and Drug Administration approved a drug by the name of Xeljanz (tofacitinib) for patients who have an insufficient or allergic response to methotrexate, as treatment for fiercely active rheumatoid arthritis. Rheumatoid arthritis (RA) is an autoimmune disease, in which the body's healthy tissue is under attack by the immune system. This leads to inflammation of the joints and surrounding tissues. RA affects about 1.5 million Americans according to the Centers for Disease Control and Prevention...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/2GbC2DjExSI/252517.php

rehab sport sport medical